Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma -- Data Supplement - Supplemental Figures -- Proceedings of the National Academy of Sciences

Supplementary material for Purkey et al. (2001) Proc. Natl. Acad. Sci. USA 98 (10), 5566–5571. (10.1073/pnas.091431798)

Fig. 8.
HPLC trace of compound 11 in conjunction with traces of compounds 10 and 12–15 (see Figs. 7 and 9–12) demonstrate the range of retention times of the compound peaks evaluated in comparison with the nonoverlapping TTR peaks.